An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Jianyang Zeng(Westlake University), Ze‐Hong Miao(Nanchang University), Hantao Shu(Tsinghua University), Hui Yang(Silexon AI Technology (China)), Xiaolong Feng(Tongji Hospital), Suling Huang(Shanghai Institute of Materia Medica), Yunan Luo(Georgia Institute of Technology), Tingzhong Tian(Tsinghua University), Yipin Lei(Tsinghua University), Lili Cheng(Tsinghua University), Xiao Liang(Convalife (China)), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Hainian Zeng(Silexon AI Technology (China)), Dan Zhao(University of Electronic Science and Technology of China), Chengliang Hu(Tsinghua University), Enming Yuan(Tsinghua University), Lixiang Hong(Tsinghua University), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Ziyuan Jiang(Tsinghua University), Chunhao Yang(Nanjing University of Chinese Medicine), Haitao Li(Center for Life Sciences), Xiaoting Wang(Silexon AI Technology (China)), Fang Wan(Translational Therapeutics (United States)), Shuya Li(Tsinghua University), Xiaokun Shen(Convalife (China)), Ligong Chen(Diagnostics for the Real World (United States)), Ying Chi(China Three Gorges University), Jingxin Li(Beijing Tongren Hospital), Yunfu Wu(Inner Mongolia Electric Power Survey & Design Institute (China)), Li Zeng(Convalife (China)), Xiling Guo(Jiangsu Provincial Center for Disease Control and Prevention), Nian Wu(Jinan University)
Cited by 204
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information
|Nature Communications|2017|884
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Allelic reprogramming of 3D chromatin architecture during early mammalian development
|Nature|2017|559
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391